Related Experiment Videos
Stress-related Mucosal Disease.
12080 Century Park East, Suite 1106, Los Angeles, CA 90067, USA. mjs5856@pol.net
Current Treatment Options in Gastroenterology
|March 12, 2003
Summary
Proton pump inhibitors (PPIs) show promise in preventing stress-related mucosal disease (SRMD) bleeding in critically ill patients. These potent acid-suppressive drugs may offer an effective tool for reducing SRMD incidence.
Area of Science:
- Gastroenterology
- Critical Care Medicine
Background:
- Stress-related mucosal disease (SRMD) encompasses superficial mucosal damage and deep focal ulcers.
- Both conditions stem from mucosal ischemia, primarily affecting the stomach's corpus and fundus.
- While stress ulcer prophylaxis can reduce bleeding, it hasn't improved survival rates.
Purpose of the Study:
- To evaluate the efficacy of proton pump inhibitors (PPIs) in preventing SRMD.
- To assess PPIs as a potential prophylactic agent for critically ill patients.
Main Methods:
- Review of preliminary studies on PPIs for SRMD prophylaxis.
- Comparison of PPIs with existing treatments like histamine H(2)-receptor antagonists.
Main Results:
- Proton pump inhibitors (PPIs) are potent acid-suppressive agents with sustained efficacy.
- Preliminary data indicate a significant reduction in SRMD bleeding with PPI prophylaxis.
- PPIs demonstrate minimal adverse effects and no tolerance development.
Conclusions:
- PPIs represent a promising therapeutic option for SRMD prophylaxis.
- Further research may establish PPIs as a key tool in managing critically ill patients at risk for SRMD.